Research graph
References from Gambogenic Acid Inhibits Tumor Angiogenesis and Growth in Canine Osteosarcoma via Fibronectin Type III and SPRY Domain Containing 1 (FSD 1) Modulation. Local targets link to admitted publications; unresolved targets remain external evidence.